Solid Tumor Genomics
Advances in understanding the genetic changes associated with solid tumors have come more slowly than with hematopoietic tumors, in large part because of difficulties in inducing the neoplastic cells of many tumors to divide in vitro. Moreover, when karyotypes are obtained, they are often found to be of inferior quality. Of 14,000 neoplasms now entered in the cytogenetic database, only 21% are solid tumors, although these are the most common tumors of man (139). Solid tumor cytogenetics is still in its infancy, but several areas of current and future clinical utility are becoming apparent.
Eligibility: Undergraduate or Postgraduate in Medicine, Life Sciences, Microbiology, Biotechnology & Biochemistry.
Seats: 60 students/course. Selection of participants on a first come first serve basis through Merit, Screening test & Interview.
Application Link: https://forms.gle/xw48263JfjWLp7EP7
Please fill out the above application form for six months duration training courses
